Epstein-barr virus can infect rabbits by the intranasal or peroral route: An animal model for natural primary EBV infection in humans

Journal of Medical Virology

Volumn 82, Issue 6, 2010, Pages 977-986

  Okuno, Keisuke ^a   Takashima, Kazuaki ^b   Kanai, Kyosuke ^a   Ohashi, Makoto ^a   Hyuga, Ryosuke ^a   Sugihara, Hirotsugu ^a   Kuwamoto, Satoshi ^a   Kato, Masako ^a   Sano, Hitoshi ^a   Sairenji, Takeshi ^a   Kanzaki, Susumu ^a   Hayashi, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Animal Clinical Research Foundation   (Japan)

Author keywords

Animal model; ELISA; Epstein Barr virus; Infection; Rabbit

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXPERIMENTAL ANIMAL; HISTOPATHOLOGY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; RABBIT; VIRUS GENE;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RABBITS; RNA, VIRAL; VIRAL PROTEINS;

ANIMALIA; HUMAN HERPESVIRUS 4; ORYCTOLAGUS CUNICULUS;

EID: 77953501170     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21597     Document Type: Article

References (36)

1. Allday MJ, Crawford DH. 1998. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours. Lancet 1:855-857.
2. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. 1995. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744-750.
3. Aozasa K. 1996. Pyothorax-associated lymphoma. Int J Hematol 65:9-16.
4. Bauer G. 2001. Simplicity through complexity: Immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clin Lab 47:223-230.
5. Bear R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Tuffnell PS, Barrell BG, Séguin C. 1984.DNAsequence and expression of theB95-8 Epstein -Barr virus genome. Nature 310:207-211.
6. Bergallo M, Costa C, Baro S, Musso T, Balbo L, Merlino C, Cavallo R. 2007. Multiplex-nested RT-PCR to evaluate latent and lytic Epstein Barr virus gene expression. J Biothechnol 128:462-476.
7. Chang KL, Chen YY, Shibata D, Weiss LM. 1992. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of a normal and neoplastic tissues. Diagn Mol Pathol 1:246-255.
8. Cocco M, Bellan C, Tussiwand R, Corti D, Traggiai E, Lazzi S, Mannucci S, Bronz L, Palummo N, Ginanneschi C, Tosi P, Lanzavecchia A, Manz MG, Leoncini L. 2008. CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection. Am J Pathol 173:1369-1378.
9. Cohen JI. 2000. Epstein-Barr virus infection. N Engl J Med 343:481-492.
10. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in culutured lymphoblasts from Barkitt's lymphoma. Lancet 15:702-703.
11. Epstein MA, zur Hausen H, Ball G, Rabin H. 1975. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). III. Serological and biochemical findings in an animal with reticuloproliferative disease. Int J Cancer 15:17-22.
12. Hayashi K, Ohara N, Teramoto N, Onoda S, Chen HL, Oka T, Kondo E, Yoshino T, Takahashi K, Yates J, Akagi T. 2001. An animal model for human EBV-associated hemophagocytic syndrome: Herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol 158:1533-1542. (Pubitemid 32281317)
13. Hayashi K, Jin Z, Onoda S, Joko H, Teramoto N, Ohara N, Oda W, Tanaka T, Liu XY, Koirala TR, Oka T, Kondo E, Yoshino T, Takahashi K, Akagi T. 2003a. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): Sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS. Am J Pathol 162:1721-1736. (Pubitemid 36512855)
14. Hayashi K, Joko H, Koirala TR, Onoda S, Jin ZS, Munemasa M, Ohara N, Oda W, Tanaka T, Oka T, Kondo E, Yoshino T, Takahashi K, Yamada M, Akagi T. 2003b. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): Effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease. Histol Histopathol 18:1155-1168. (Pubitemid 37265018)
15. Henle W, Henle G, Anderson J, Emberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE. 1987. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 84:570-574.
16. Hsieh WC, Chang Y, Hsu MC, Lan BS, Hsiao GC, Chuang HC, Su IJ. 2007. Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophage in a rabbitmodel of Epstein-Barr virus-associated hemophagocytic syndrome. Am J Pathol 170:1629-1639.
17. Imashuku S. 2002. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259-272. (Pubitemid 35435291)
18. Isaacson P, Wright DH. 1983. Malignant lymphoma of mucosa-associated lymphoid tissue: A distinct type of B-cell lymphoma. Cancer 52:1410-1416.
19. Johannessen I, Crawford DH. 1999. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev Med Virol 9:263-277.
20. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37:132-136.
21. Kimura H, Ito Y, Suzuki R, Nishiyama Y. 2008. Measureing Epstein-Barr virus (EBV) load: The significance and application for each EBV-associated disease. Rev Med Virol 18:305-319.
22. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV. 2006. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316-1322.
23. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259.
24. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. 1997. Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells. J Pathol 182:151-159.
25. Rivailler P, Carville A, Kaur A, Rao P, Quink C, Kutok JL, Westmoreland S, Klumpp S, Aster JC, Wang F. 2004. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: An animal model for Epstein-Barr virus pathogenesis in the immuno-suppressed host. Blood 104:1482-1489.
26. Schillinger M, Kampmann M, Henninger K, Murray G, Hanselmann I, Bauer G. 1993. Variability of humoral immune response to acute Epstein-Barr virus (EBV)infection:Evaluation of the significance of serological markers. Med Microbiol Lett 2:296-303.
27. Scott RS, Moody CA, Sixbey JW. 2005. In: Robertson ES, editor. Epstein-Barr virus and oral malignancy. England: Caister Academic Press. pp 55-70.
28. Shope T, Dechairo D, Miller G. 1973. Malignant lymphoma in cottontop marmosets after inoculation with Epastein-Barr virus. Proc Matl Acad Sci 70:2487-2491.
29. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 10:1225-1230.
30. Straus SE. 1988. The chronic mononucleosis syndrome. J Infect Dis 157:405-412.
31. Straus SE, Cohen JI, Tosato G, Meier J. 1993. NIH conference: Epstein-Barr virus infections: Biology, pathology, and management. Ann Intern Med 118:45-58.
32. Sugimoto M, Tahara H, Ide T, Furuichi Y. 2004. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 64: 3361-3364. (Pubitemid 38657904)
33. Takashima K, Ohashi M, Kitamura Y, Ando K, Nagashima K, Sugihara H, Okuno K, Sairenji T, Hayashi K. 2008. A new animal model for primary and persistent Epstein-Barr virus infection: Human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. J Med Virol 80:455-466.
34. Tsurumi T, Fujita M, Kudoh A. 2005. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15:3-15.
35. Williams H, Crawford DH. 2006. Epstein-Barr virus: The impact of science advances on clinical practice. Blood 107:862-869.
36. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Honda M, Yamamoto N, Fujiwara S. 2008. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 198:673-682.